83 related articles for article (PubMed ID: 35035433)
1. Time to negative PCR in various disease categories of COVID-19 infection in Pakistani population.
Toori KU; Chaudhry A; Qureshi MA
Pak J Med Sci; 2022; 38(1):243-247. PubMed ID: 35035433
[TBL] [Abstract][Full Text] [Related]
2. Pre-morbidity and COVID-19 disease outcomes in Pakistani population: A cross-sectional study.
Toori KU; Qureshi MA; Chaudhry A
Pak J Med Sci; 2022; 38(1):287-292. PubMed ID: 35035441
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting.
Toori KU; Qureshi MA; Chaudhry A; Safdar MF
Pak J Med Sci; 2021; 37(5):1435-1439. PubMed ID: 34475926
[TBL] [Abstract][Full Text] [Related]
4. Lymphopenia: A useful predictor of COVID-19 disease severity and mortality.
Toori KU; Qureshi MA; Chaudhry A
Pak J Med Sci; 2021; 37(7):1984-1988. PubMed ID: 34912430
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Oxygen Therapy Post COVID-19 Infection: Factors Leading to the Risk of Poor Outcome.
Ray A; Chaudhry R; Rai S; Mitra S; Pradhan S; Sunder A; Nag DS
Cureus; 2021 Feb; 13(2):e13357. PubMed ID: 33633916
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
Şık N; Özlü C; Karaoğlu Asrak H; Erbaş İC; Çakıl Güzin A; Atakul G; Atay Ö; Appak Ö; Sayıner AA; Uzuner N; Asilsoy S; Belet N; Yılmaz D; Duman M
Mikrobiyol Bul; 2020 Oct; 54(4):629-637. PubMed ID: 33107292
[TBL] [Abstract][Full Text] [Related]
7. The clinical and demographical profile of Coronavirus illness: The tale of
Ujjan ID; Devrajani BR; Ghanghro AA; Shah SZA
Pak J Med Sci; 2020 May; 36(COVID19-S4):S12-S16. PubMed ID: 32582307
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
9. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
11. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
12. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irrespective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India.
Gupta A; Nayan N; Nair R; Kumar K; Joshi A; Sharma S; Singh J; Kapoor R
SN Compr Clin Med; 2021; 3(4):937-944. PubMed ID: 33718779
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of Real Time PCR Cycle Threshold Values in Symptomatic and Asymptomatic COVID-19 Patients].
Gülbudak H; Karvar Ş; Soydan G; Tezcan Ülger S; Kandemir Ö; Tamer L; Altunkan AA; Özdemir AA; Aslan G
Mikrobiyol Bul; 2021 Jul; 55(3):435-444. PubMed ID: 34416808
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
[TBL] [Abstract][Full Text] [Related]
16. Screening of Asymptomatic Healthcare Workers for SARS-COV-2 for Occult Infections: A Cross-Sectional Study.
Tadi LJ; Chunchu SR; M S; Mallamgunta S; Ravula U; K A; Dara C; Sandepogu TS
Cureus; 2021 Nov; 13(11):e19341. PubMed ID: 34909302
[TBL] [Abstract][Full Text] [Related]
17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
18. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
19. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases.
Danics K; Pesti A; Törő K; Kiss-Dala N; Szlávik J; Lakatos B; Radnai A; Balázs T; Bacskai M; Dobi D; Várkonyi T; Glasz T; Lotz G; Kiss A; Schaff Z; Vályi-Nagy I
Geroscience; 2021 Oct; 43(5):2265-2287. PubMed ID: 34510338
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of Covid-19 Infection: a Study of SARS-CoV-2 Positive Patients from Mymensingh Region, in Bangladesh.
Barman TK; Roy S; Nasreen SA; Ahmed S; Khanam J; Nila SS; Debnath P; Khaled FI; Paul SK
Mymensingh Med J; 2021 Jul; 30(3):666-670. PubMed ID: 34226453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
